Biotech Stocks Surge To Start 2024: 'Charts Look Great,' But Will The Trend Continue?
The biotech sector has been surging in recent months, reawakening from a period of underperformance that followed the highs of 2021. David Prince, professional trader at T3 Trading Group, joined Benzinga's PreMarket Prep on Tuesday and discussed the biotech industry and Viking Therapeutics and Immunome as notable recent movers.
